Global Insulin Glargine Market Insights, Forecast to 2028

Global Insulin Glargine Market Insights, Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Insulin Glargine Product Introduction
1.2 Market by Type
1.2.1 Global Insulin Glargine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Prefilled Injection
1.2.3 Non-Prefilled Injection
1.3 Market by Application
1.3.1 Global Insulin Glargine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Type 1 Diabetes Treatment
1.3.3 Type 2 Diabetes Treatment
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Insulin Glargine Sales Estimates and Forecasts 2017-2028
2.2 Global Insulin Glargine Revenue Estimates and Forecasts 2017-2028
2.3 Global Insulin Glargine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Insulin Glargine Sales by Region
2.4.1 Global Insulin Glargine Sales by Region (2017-2022)
2.4.2 Global Sales Insulin Glargine by Region (2023-2028)
2.5 Global Insulin Glargine Revenue by Region
2.5.1 Global Insulin Glargine Revenue by Region (2017-2022)
2.5.2 Global Insulin Glargine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Insulin Glargine Sales by Manufacturers
3.1.1 Global Top Insulin Glargine Manufacturers by Sales (2017-2022)
3.1.2 Global Insulin Glargine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Insulin Glargine in 2021
3.2 Global Insulin Glargine Revenue by Manufacturers
3.2.1 Global Insulin Glargine Revenue by Manufacturers (2017-2022)
3.2.2 Global Insulin Glargine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Glargine Revenue in 2021
3.3 Global Insulin Glargine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Insulin Glargine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Insulin Glargine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Insulin Glargine Sales by Type
4.1.1 Global Insulin Glargine Historical Sales by Type (2017-2022)
4.1.2 Global Insulin Glargine Forecasted Sales by Type (2023-2028)
4.1.3 Global Insulin Glargine Sales Market Share by Type (2017-2028)
4.2 Global Insulin Glargine Revenue by Type
4.2.1 Global Insulin Glargine Historical Revenue by Type (2017-2022)
4.2.2 Global Insulin Glargine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Insulin Glargine Revenue Market Share by Type (2017-2028)
4.3 Global Insulin Glargine Price by Type
4.3.1 Global Insulin Glargine Price by Type (2017-2022)
4.3.2 Global Insulin Glargine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Insulin Glargine Sales by Application
5.1.1 Global Insulin Glargine Historical Sales by Application (2017-2022)
5.1.2 Global Insulin Glargine Forecasted Sales by Application (2023-2028)
5.1.3 Global Insulin Glargine Sales Market Share by Application (2017-2028)
5.2 Global Insulin Glargine Revenue by Application
5.2.1 Global Insulin Glargine Historical Revenue by Application (2017-2022)
5.2.2 Global Insulin Glargine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Insulin Glargine Revenue Market Share by Application (2017-2028)
5.3 Global Insulin Glargine Price by Application
5.3.1 Global Insulin Glargine Price by Application (2017-2022)
5.3.2 Global Insulin Glargine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Insulin Glargine Market Size by Type
6.1.1 North America Insulin Glargine Sales by Type (2017-2028)
6.1.2 North America Insulin Glargine Revenue by Type (2017-2028)
6.2 North America Insulin Glargine Market Size by Application
6.2.1 North America Insulin Glargine Sales by Application (2017-2028)
6.2.2 North America Insulin Glargine Revenue by Application (2017-2028)
6.3 North America Insulin Glargine Market Size by Country
6.3.1 North America Insulin Glargine Sales by Country (2017-2028)
6.3.2 North America Insulin Glargine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Insulin Glargine Market Size by Type
7.1.1 Europe Insulin Glargine Sales by Type (2017-2028)
7.1.2 Europe Insulin Glargine Revenue by Type (2017-2028)
7.2 Europe Insulin Glargine Market Size by Application
7.2.1 Europe Insulin Glargine Sales by Application (2017-2028)
7.2.2 Europe Insulin Glargine Revenue by Application (2017-2028)
7.3 Europe Insulin Glargine Market Size by Country
7.3.1 Europe Insulin Glargine Sales by Country (2017-2028)
7.3.2 Europe Insulin Glargine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Insulin Glargine Market Size by Type
8.1.1 Asia Pacific Insulin Glargine Sales by Type (2017-2028)
8.1.2 Asia Pacific Insulin Glargine Revenue by Type (2017-2028)
8.2 Asia Pacific Insulin Glargine Market Size by Application
8.2.1 Asia Pacific Insulin Glargine Sales by Application (2017-2028)
8.2.2 Asia Pacific Insulin Glargine Revenue by Application (2017-2028)
8.3 Asia Pacific Insulin Glargine Market Size by Region
8.3.1 Asia Pacific Insulin Glargine Sales by Region (2017-2028)
8.3.2 Asia Pacific Insulin Glargine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Insulin Glargine Market Size by Type
9.1.1 Latin America Insulin Glargine Sales by Type (2017-2028)
9.1.2 Latin America Insulin Glargine Revenue by Type (2017-2028)
9.2 Latin America Insulin Glargine Market Size by Application
9.2.1 Latin America Insulin Glargine Sales by Application (2017-2028)
9.2.2 Latin America Insulin Glargine Revenue by Application (2017-2028)
9.3 Latin America Insulin Glargine Market Size by Country
9.3.1 Latin America Insulin Glargine Sales by Country (2017-2028)
9.3.2 Latin America Insulin Glargine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Insulin Glargine Market Size by Type
10.1.1 Middle East and Africa Insulin Glargine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Insulin Glargine Revenue by Type (2017-2028)
10.2 Middle East and Africa Insulin Glargine Market Size by Application
10.2.1 Middle East and Africa Insulin Glargine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Insulin Glargine Revenue by Application (2017-2028)
10.3 Middle East and Africa Insulin Glargine Market Size by Country
10.3.1 Middle East and Africa Insulin Glargine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Insulin Glargine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Corporation Information
11.2.2 Eli Lilly Overview
11.2.3 Eli Lilly Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Eli Lilly Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Eli Lilly Recent Developments
11.3 Viatris
11.3.1 Viatris Corporation Information
11.3.2 Viatris Overview
11.3.3 Viatris Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Viatris Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Viatris Recent Developments
11.4 Gan&Lee Pharmaceuticals
11.4.1 Gan&Lee Pharmaceuticals Corporation Information
11.4.2 Gan&Lee Pharmaceuticals Overview
11.4.3 Gan&Lee Pharmaceuticals Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Gan&Lee Pharmaceuticals Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Gan&Lee Pharmaceuticals Recent Developments
11.5 Tonghua Dongbao Pharmaceutical
11.5.1 Tonghua Dongbao Pharmaceutical Corporation Information
11.5.2 Tonghua Dongbao Pharmaceutical Overview
11.5.3 Tonghua Dongbao Pharmaceutical Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Tonghua Dongbao Pharmaceutical Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tonghua Dongbao Pharmaceutical Recent Developments
11.6 United Laboratories International
11.6.1 United Laboratories International Corporation Information
11.6.2 United Laboratories International Overview
11.6.3 United Laboratories International Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 United Laboratories International Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 United Laboratories International Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Insulin Glargine Industry Chain Analysis
12.2 Insulin Glargine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Insulin Glargine Production Mode & Process
12.4 Insulin Glargine Sales and Marketing
12.4.1 Insulin Glargine Sales Channels
12.4.2 Insulin Glargine Distributors
12.5 Insulin Glargine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Insulin Glargine Industry Trends
13.2 Insulin Glargine Market Drivers
13.3 Insulin Glargine Market Challenges
13.4 Insulin Glargine Market Restraints
14 Key Findings in The Global Insulin Glargine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Insulin Glargine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Prefilled Injection
Table 3. Major Manufacturers of Non-Prefilled Injection
Table 4. Global Insulin Glargine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Insulin Glargine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Insulin Glargine Sales by Region (2017-2022) & (M mL)
Table 7. Global Insulin Glargine Sales Market Share by Region (2017-2022)
Table 8. Global Insulin Glargine Sales by Region (2023-2028) & (M mL)
Table 9. Global Insulin Glargine Sales Market Share by Region (2023-2028)
Table 10. Global Insulin Glargine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Insulin Glargine Revenue Market Share by Region (2017-2022)
Table 12. Global Insulin Glargine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Insulin Glargine Revenue Market Share by Region (2023-2028)
Table 14. Global Insulin Glargine Sales by Manufacturers (2017-2022) & (M mL)
Table 15. Global Insulin Glargine Sales Share by Manufacturers (2017-2022)
Table 16. Global Insulin Glargine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Insulin Glargine Revenue Share by Manufacturers (2017-2022)
Table 18. Insulin Glargine Price by Manufacturers (2017-2022) &(USD/mL)
Table 19. Global Insulin Glargine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Insulin Glargine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Glargine as of 2021)
Table 21. Insulin Glargine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Insulin Glargine Product Offered
Table 23. Date of Manufacturers Enter into Insulin Glargine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Insulin Glargine Sales by Type (2017-2022) & (M mL)
Table 26. Global Insulin Glargine Sales by Type (2023-2028) & (M mL)
Table 27. Global Insulin Glargine Sales Share by Type (2017-2022)
Table 28. Global Insulin Glargine Sales Share by Type (2023-2028)
Table 29. Global Insulin Glargine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Insulin Glargine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Insulin Glargine Revenue Share by Type (2017-2022)
Table 32. Global Insulin Glargine Revenue Share by Type (2023-2028)
Table 33. Insulin Glargine Price by Type (2017-2022) & (USD/mL)
Table 34. Global Insulin Glargine Price Forecast by Type (2023-2028) & (USD/mL)
Table 35. Global Insulin Glargine Sales by Application (2017-2022) & (M mL)
Table 36. Global Insulin Glargine Sales by Application (2023-2028) & (M mL)
Table 37. Global Insulin Glargine Sales Share by Application (2017-2022)
Table 38. Global Insulin Glargine Sales Share by Application (2023-2028)
Table 39. Global Insulin Glargine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Insulin Glargine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Insulin Glargine Revenue Share by Application (2017-2022)
Table 42. Global Insulin Glargine Revenue Share by Application (2023-2028)
Table 43. Insulin Glargine Price by Application (2017-2022) & (USD/mL)
Table 44. Global Insulin Glargine Price Forecast by Application (2023-2028) & (USD/mL)
Table 45. North America Insulin Glargine Sales by Type (2017-2022) & (M mL)
Table 46. North America Insulin Glargine Sales by Type (2023-2028) & (M mL)
Table 47. North America Insulin Glargine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Insulin Glargine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Insulin Glargine Sales by Application (2017-2022) & (M mL)
Table 50. North America Insulin Glargine Sales by Application (2023-2028) & (M mL)
Table 51. North America Insulin Glargine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Insulin Glargine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Insulin Glargine Sales by Country (2017-2022) & (M mL)
Table 54. North America Insulin Glargine Sales by Country (2023-2028) & (M mL)
Table 55. North America Insulin Glargine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Insulin Glargine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Insulin Glargine Sales by Type (2017-2022) & (M mL)
Table 58. Europe Insulin Glargine Sales by Type (2023-2028) & (M mL)
Table 59. Europe Insulin Glargine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Insulin Glargine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Insulin Glargine Sales by Application (2017-2022) & (M mL)
Table 62. Europe Insulin Glargine Sales by Application (2023-2028) & (M mL)
Table 63. Europe Insulin Glargine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Insulin Glargine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Insulin Glargine Sales by Country (2017-2022) & (M mL)
Table 66. Europe Insulin Glargine Sales by Country (2023-2028) & (M mL)
Table 67. Europe Insulin Glargine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Insulin Glargine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Insulin Glargine Sales by Type (2017-2022) & (M mL)
Table 70. Asia Pacific Insulin Glargine Sales by Type (2023-2028) & (M mL)
Table 71. Asia Pacific Insulin Glargine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Insulin Glargine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Insulin Glargine Sales by Application (2017-2022) & (M mL)
Table 74. Asia Pacific Insulin Glargine Sales by Application (2023-2028) & (M mL)
Table 75. Asia Pacific Insulin Glargine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Insulin Glargine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Insulin Glargine Sales by Region (2017-2022) & (M mL)
Table 78. Asia Pacific Insulin Glargine Sales by Region (2023-2028) & (M mL)
Table 79. Asia Pacific Insulin Glargine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Insulin Glargine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Insulin Glargine Sales by Type (2017-2022) & (M mL)
Table 82. Latin America Insulin Glargine Sales by Type (2023-2028) & (M mL)
Table 83. Latin America Insulin Glargine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Insulin Glargine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Insulin Glargine Sales by Application (2017-2022) & (M mL)
Table 86. Latin America Insulin Glargine Sales by Application (2023-2028) & (M mL)
Table 87. Latin America Insulin Glargine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Insulin Glargine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Insulin Glargine Sales by Country (2017-2022) & (M mL)
Table 90. Latin America Insulin Glargine Sales by Country (2023-2028) & (M mL)
Table 91. Latin America Insulin Glargine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Insulin Glargine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Insulin Glargine Sales by Type (2017-2022) & (M mL)
Table 94. Middle East and Africa Insulin Glargine Sales by Type (2023-2028) & (M mL)
Table 95. Middle East and Africa Insulin Glargine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Insulin Glargine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Insulin Glargine Sales by Application (2017-2022) & (M mL)
Table 98. Middle East and Africa Insulin Glargine Sales by Application (2023-2028) & (M mL)
Table 99. Middle East and Africa Insulin Glargine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Insulin Glargine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Insulin Glargine Sales by Country (2017-2022) & (M mL)
Table 102. Middle East and Africa Insulin Glargine Sales by Country (2023-2028) & (M mL)
Table 103. Middle East and Africa Insulin Glargine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Insulin Glargine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Major Businesses
Table 107. Sanofi Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
Table 108. Sanofi Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Sanofi Recent Developments
Table 110. Eli Lilly Corporation Information
Table 111. Eli Lilly Description and Major Businesses
Table 112. Eli Lilly Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
Table 113. Eli Lilly Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Eli Lilly Recent Developments
Table 115. Viatris Corporation Information
Table 116. Viatris Description and Major Businesses
Table 117. Viatris Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
Table 118. Viatris Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Viatris Recent Developments
Table 120. Gan&Lee Pharmaceuticals Corporation Information
Table 121. Gan&Lee Pharmaceuticals Description and Major Businesses
Table 122. Gan&Lee Pharmaceuticals Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
Table 123. Gan&Lee Pharmaceuticals Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Gan&Lee Pharmaceuticals Recent Developments
Table 125. Tonghua Dongbao Pharmaceutical Corporation Information
Table 126. Tonghua Dongbao Pharmaceutical Description and Major Businesses
Table 127. Tonghua Dongbao Pharmaceutical Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
Table 128. Tonghua Dongbao Pharmaceutical Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Tonghua Dongbao Pharmaceutical Recent Developments
Table 130. United Laboratories International Corporation Information
Table 131. United Laboratories International Description and Major Businesses
Table 132. United Laboratories International Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
Table 133. United Laboratories International Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. United Laboratories International Recent Developments
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Insulin Glargine Distributors List
Table 138. Insulin Glargine Customers List
Table 139. Insulin Glargine Market Trends
Table 140. Insulin Glargine Market Drivers
Table 141. Insulin Glargine Market Challenges
Table 142. Insulin Glargine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Glargine Product Picture
Figure 3. Global Insulin Glargine Market Share by Type in 2021 & 2028
Figure 3. Prefilled Injection Product Picture
Figure 4. Non-Prefilled Injection Product Picture
Figure 5. Global Insulin Glargine Market Share by Application in 2021 & 2028
Figure 6. Type 1 Diabetes Treatment
Figure 7. Type 2 Diabetes Treatment
Figure 8. Insulin Glargine Report Years Considered
Figure 9. Global Insulin Glargine Sales 2017-2028 (M mL)
Figure 10. Global Insulin Glargine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Insulin Glargine Revenue 2017-2028 (US$ Million)
Figure 12. Global Insulin Glargine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Insulin Glargine Sales Market Share by Region (2017-2022)
Figure 14. Global Insulin Glargine Sales Market Share by Region (2023-2028)
Figure 15. North America Insulin Glargine Sales YoY (2017-2028) & (M mL)
Figure 16. North America Insulin Glargine Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Insulin Glargine Sales YoY (2017-2028) & (M mL)
Figure 18. Europe Insulin Glargine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Insulin Glargine Sales YoY (2017-2028) & (M mL)
Figure 20. Asia-Pacific Insulin Glargine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Insulin Glargine Sales YoY (2017-2028) & (M mL)
Figure 22. Latin America Insulin Glargine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Insulin Glargine Sales YoY (2017-2028) & (M mL)
Figure 24. Middle East & Africa Insulin Glargine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Insulin Glargine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Insulin Glargine in the World: Market Share by Insulin Glargine Revenue in 2021
Figure 27. Global Insulin Glargine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Insulin Glargine Sales Market Share by Type (2017-2028)
Figure 29. Global Insulin Glargine Revenue Market Share by Type (2017-2028)
Figure 30. Global Insulin Glargine Sales Market Share by Application (2017-2028)
Figure 31. Global Insulin Glargine Revenue Market Share by Application (2017-2028)
Figure 32. North America Insulin Glargine Sales Market Share by Type (2017-2028)
Figure 33. North America Insulin Glargine Revenue Market Share by Type (2017-2028)
Figure 34. North America Insulin Glargine Sales Market Share by Application (2017-2028)
Figure 35. North America Insulin Glargine Revenue Market Share by Application (2017-2028)
Figure 36. North America Insulin Glargine Sales Share by Country (2017-2028)
Figure 37. North America Insulin Glargine Revenue Share by Country (2017-2028)
Figure 38. U.S. Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Insulin Glargine Sales Market Share by Type (2017-2028)
Figure 41. Europe Insulin Glargine Revenue Market Share by Type (2017-2028)
Figure 42. Europe Insulin Glargine Sales Market Share by Application (2017-2028)
Figure 43. Europe Insulin Glargine Revenue Market Share by Application (2017-2028)
Figure 44. Europe Insulin Glargine Sales Share by Country (2017-2028)
Figure 45. Europe Insulin Glargine Revenue Share by Country (2017-2028)
Figure 46. Germany Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 47. France Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Insulin Glargine Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Insulin Glargine Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Insulin Glargine Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Insulin Glargine Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Insulin Glargine Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Insulin Glargine Revenue Share by Region (2017-2028)
Figure 57. China Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 60. India Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Insulin Glargine Sales Market Share by Type (2017-2028)
Figure 67. Latin America Insulin Glargine Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Insulin Glargine Sales Market Share by Application (2017-2028)
Figure 69. Latin America Insulin Glargine Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Insulin Glargine Sales Share by Country (2017-2028)
Figure 71. Latin America Insulin Glargine Revenue Share by Country (2017-2028)
Figure 72. Mexico Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 75. Middle East and Africa Insulin Glargine Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Insulin Glargine Revenue Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Insulin Glargine Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Insulin Glargine Revenue Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Insulin Glargine Sales Share by Country (2017-2028)
Figure 80. Middle East and Africa Insulin Glargine Revenue Share by Country (2017-2028)
Figure 81. Turkey Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 82. Saudi Arabia Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 83. UAE Insulin Glargine Revenue (2017-2028) & (US$ Million)
Figure 84. Insulin Glargine Value Chain
Figure 85. Insulin Glargine Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Metformin Hydrochloride Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......

Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......

Global Insulin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......

Global Insulin API Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......

Global Glucagon Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Acarbose Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Insulin Glargine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77

According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......

Global Liraglutide Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103

According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs